J&J Recalls Children's Benadryl, Motrin

NEW BRUNSWICK, N.J. ( TheStreet) -- Johnson & Johnson ( JNJ) plans to recall Children's Benadryl allergy tablets and junior-strength Motrin caplets because of manufacturing problems.

J&J's McNeil Consumer Healthcare division was recalling the products because of "insufficiencies in the development of the manufacturing process," the company said.

On its Web site, McNeil said the recall was at the wholesale and retail level. "No action is required by consumers or healthcare providers and consumers can continue to use the product," McNeil said.

Bloomberg reports 4 million packages of Children's Benadryl allergy tablets and about 800,000 bottles of junior-strength Motrin caplets would be recalled.

A notice dated Nov. 15 was posted on the McNeil Web site, but no press release was issued.

J&J has issued a number of recalls this year, the latest on Oct. 18, when McNeil announced the recall of one product lot of 50-count bottles of Tylenol eight-hour caplets in the U.S. and Puerto Rico because of a strange musty or moldy odor.

-- Written by Joseph Woelfel

>To contact the writer of this article, click here: Joseph Woelfel

>To submit a news tip, send an email to: tips@thestreet.com.

More from Stocks

Danica Patrick's Final Race at 2018 Indianapolis 500: What She Thinks About Cars

Danica Patrick's Final Race at 2018 Indianapolis 500: What She Thinks About Cars

Why The FANG Stocks' Dominance May Not Be So Bad For The Market

Why The FANG Stocks' Dominance May Not Be So Bad For The Market

At End of May, Investors Signalling They May Stay Away

At End of May, Investors Signalling They May Stay Away

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Neel Kashkari: The Heart of Our Financial System Is More Radioactive Than Ever

Neel Kashkari: The Heart of Our Financial System Is More Radioactive Than Ever